Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyotax in Advanced Hormone Refractory Prostate Cancer
NCT00446836Phase 2Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Mar 2005
- Primary completion
- Nov 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in prostate cancer (PCa), sponsored by Houston Methodist Research Institute. Started Mar 2005; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00446836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446836.